| 1 | Type 2 diabetes mellitus | Enrichment | AKT2, GCK, HNF1A, HNF1B, HNF4A, NEUROD1, PDX1, RBPJ, SLC2A2 | 11.20 |
| 2 | Maturity-onset diabetes of the young | Enrichment | GCK, HNF1A, HNF1B, HNF4A, INS, NEUROD1, PDX1, PTF1A, RFX6 | 10.91 |
| 3 | Diabetes mellitus | Enrichment | GCK, HNF1A, INS, RFX6 | 8.85 |
| 4 | Maturity-onset diabetes of the young, type 3 | Enrichment | GCK, HNF1A, HNF4A | 7.89 |
| 5 | Permanent neonatal diabetes mellitus | Enrichment | GCK, INS, PDX1 | 6.75 |
| 6 | Pancreas, dorsal, agenesis of | Enrichment | PDX1, PTF1A | 6.52 |
| 7 | Maturity-onset diabetes of the young, type 1 | Enrichment | GCK, HNF4A | 5.64 |
| 8 | Hyperinsulinism due to hnf1a deficiency | Enrichment | HNF1A, HNF4A | 5.64 |
| 9 | Rubinstein-taybi syndrome 1 | Enrichment | CREBBP, EP300 | 4.71 |
| 10 | Chromosome 16p13.3 deletion syndrome, proximal | Enrichment | CREBBP, EP300 | 4.71 |
| 11 | Chromophobe renal cell carcinoma | Enrichment | HNF1A, HNF1B | 4.57 |
| 12 | Adams-oliver syndrome | Enrichment | NOTCH1, RBPJ | 4.56 |
| 13 | Type 1 diabetes mellitus | Enrichment | HNF1A, INS | 4.47 |
| 14 | Rare genetic intellectual disability | Enrichment | CREBBP, EP300 | 3.87 |
| 15 | Diarrhea 4, malabsorptive, congenital, with diabetes mellitus and combined pituitary hormone deficiency | Enrichment | NEUROG3 | 3.53 |
| 16 | Maturity-onset diabetes of the young, type 6 | Enrichment | NEUROD1 | 3.53 |
| 17 | Pancreatic agenesis 1 | Enrichment | PDX1 | 3.23 |
| 18 | Maturity-onset diabetes of the young, type 4 | Enrichment | PDX1 | 3.23 |
| 19 | Prostate cancer, hereditary, 11 | Enrichment | HNF1B | 3.23 |
| 20 | Pancreatic and cerebellar agenesis | Enrichment | PTF1A | 3.23 |
| 21 | Aplasia of lacrimal and salivary glands | Enrichment | FGF10 | 3.23 |
| 22 | Lacrimoauriculodentodigital syndrome 3 | Enrichment | FGF10 | 3.23 |
| 23 | Medullary sponge kidney | Enrichment | HNF1B | 3.23 |
| 24 | Renal dysplasia, bilateral | Enrichment | HNF1B | 3.23 |
| 25 | Unilateral multicystic dysplastic kidney | Enrichment | HNF1B | 3.23 |
| 26 | Renal dysplasia, unilateral | Enrichment | HNF1B | 3.23 |
| 27 | Interstitial lung disease specific to childhood | Enrichment | FGF10 | 3.23 |
| 28 | Renal cell carcinoma, nonpapillary | Enrichment | HNF1A, HNF1B | 3.04 |
| 29 | Tubulointerstitial kidney disease, autosomal dominant 1 | Enrichment | HNF1B | 2.93 |
| 30 | Renal cysts and diabetes syndrome | Enrichment | HNF1B | 2.93 |
| 31 | Congenital anomalies of kidney and urinary tract 2 | Enrichment | HNF1B | 2.93 |
| 32 | Pulmonary hypoplasia, primary | Enrichment | FGF10 | 2.93 |
| 33 | Kallikrein, decreased urinary activity of | Enrichment | PTF1A | 2.93 |
| 34 | Hyperuricemic nephropathy, familial juvenile, 3 | Enrichment | HNF1B | 2.93 |
| 35 | Pancreatic agenesis 2 | Enrichment | PTF1A | 2.93 |
| 36 | Hypospadias 2, x-linked | Enrichment | MAMLD1 | 2.93 |
| 37 | Menke-hennekam syndrome 1 | Enrichment | CREBBP | 2.93 |
| 38 | Rubinstein-taybi syndrome due to 16p13.3 microdeletion | Enrichment | CREBBP | 2.93 |
| 39 | Menke-hennekam syndrome | Enrichment | CREBBP | 2.93 |
| 40 | 46,xy ovotesticular disorder of sex development | Enrichment | MAMLD1 | 2.93 |
| 41 | Diffuse large b-cell lymphoma | Enrichment | CREBBP, FOXO1 | 2.83 |
| 42 | Adenosine triphosphate, elevated, of erythrocytes | Enrichment | PKLR | 2.81 |
| 43 | Proteus syndrome | Enrichment | AKT1 | 2.81 |
| 44 | Insulinomatosis and diabetes mellitus | Enrichment | MAFA | 2.81 |
| 45 | Hepatic adenomas, familial | Enrichment | HNF1A | 2.81 |
| 46 | Hypoinsulinemic hypoglycemia with hemihypertrophy | Enrichment | AKT2 | 2.81 |
| 47 | Anemia, congenital, nonspherocytic hemolytic, 2 | Enrichment | PKLR | 2.81 |
| 48 | Maturity-onset diabetes of the young, type 2 | Enrichment | GCK | 2.81 |
| 49 | Fanconi renotubular syndrome 4 with maturity-onset diabetes of the young | Enrichment | HNF4A | 2.81 |
| 50 | Mitchell-riley syndrome | Enrichment | RFX6 | 2.81 |
| 51 | Hyperinsulinemic hypoglycemia, familial, 3 | Enrichment | GCK | 2.81 |
| 52 | Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2 | Enrichment | AKT3 | 2.81 |
| 53 | Cowden syndrome 6 | Enrichment | AKT1 | 2.81 |
| 54 | Type 1 diabetes mellitus 20 | Enrichment | HNF1A | 2.81 |
| 55 | Capillary hemangioma | Enrichment | AKT3 | 2.81 |
| 56 | Non-acquired combined pituitary hormone deficiency | Enrichment | FOXA2 | 2.81 |
| 57 | Gestational diabetes | Enrichment | GCK | 2.81 |
| 58 | Hyperinsulinism due to hnf4a deficiency | Enrichment | HNF4A | 2.81 |
| 59 | Akt2-related familial partial lipodystrophy | Enrichment | AKT2 | 2.81 |
| 60 | Lacrimoauriculodentodigital syndrome 1 | Enrichment | FGF10 | 2.75 |
| 61 | Mullerian duct aplasia, unilateral renal agenesis, and cervicothoracic somite anomalies | Enrichment | HNF1B | 2.75 |
| 62 | Chromosome 17q12 deletion syndrome | Enrichment | HNF1B | 2.75 |
| 63 | Thumb deformity | Enrichment | CREBBP | 2.63 |
| 64 | Adams-oliver syndrome 5 | Enrichment | NOTCH1 | 2.63 |
| 65 | Adams-oliver syndrome 3 | Enrichment | RBPJ | 2.63 |
| 66 | Menke-hennekam syndrome 2 | Enrichment | EP300 | 2.63 |
| 67 | Acute myeloid leukemia with kat6a-crebbp fusion | Enrichment | CREBBP | 2.63 |
| 68 | Posterior hypospadias | Enrichment | MAMLD1 | 2.63 |
| 69 | X-linked myotubular myopathy-abnormal genitalia syndrome | Enrichment | MAMLD1 | 2.63 |
| 70 | Keratitis, hereditary | Enrichment | PAX6 | 2.51 |
| 71 | Foveal hypoplasia 1 | Enrichment | PAX6 | 2.51 |
| 72 | Fanconi-bickel syndrome | Enrichment | SLC2A2 | 2.51 |
| 73 | Diabetes mellitus, permanent neonatal, 1 | Enrichment | GCK | 2.51 |
| 74 | Bone marrow failure syndrome 2 | Enrichment | GCK | 2.51 |
| 75 | Optic nerve hypoplasia, bilateral | Enrichment | PAX6 | 2.51 |
| 76 | Maturity-onset diabetes of the young, type 10 | Enrichment | INS | 2.51 |
| 77 | Hyperproinsulinemia | Enrichment | INS | 2.51 |
| 78 | Senior-loken syndrome 7 | Enrichment | AKT3 | 2.51 |
| 79 | Diabetes mellitus, permanent neonatal, 4 | Enrichment | INS | 2.51 |
| 80 | Bardet-biedl syndrome 16 | Enrichment | AKT3 | 2.51 |
| 81 | Hyperinsulinism | Enrichment | HNF4A | 2.51 |
| 82 | Ovarian cancer | Enrichment | AKT1, HNF1A, HNF1B | 2.46 |
| 83 | Tethered spinal cord syndrome | Enrichment | CREBBP | 2.45 |
| 84 | Intraocular pressure quantitative trait locus | Enrichment | CREBBP | 2.45 |
| 85 | Keratoacanthoma | Enrichment | NOTCH1 | 2.45 |
| 86 | Type 1 diabetes mellitus 2 | Enrichment | INS | 2.33 |
| 87 | Nijmegen breakage syndrome | Enrichment | GCK | 2.33 |
| 88 | Gillespie syndrome | Enrichment | PAX6 | 2.33 |
| 89 | Keratoderma-ichthyosis-deafness syndrome, autosomal recessive | Enrichment | HNF1A | 2.33 |
| 90 | Orofacial cleft 1 | Enrichment | FGF10 | 2.28 |
| 91 | Rubinstein-taybi syndrome 2 | Enrichment | EP300 | 2.23 |
| 92 | Breast cancer | Enrichment | AKT1, HNF1A | 2.23 |
| 93 | Aniridia 1 | Enrichment | PAX6 | 2.21 |
| 94 | Megalencephaly-capillary malformation-polymicrogyria syndrome | Enrichment | AKT3 | 2.21 |
| 95 | Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1 | Enrichment | AKT3 | 2.21 |
| 96 | Neonatal diabetes mellitus | Enrichment | INS | 2.21 |
| 97 | Eyelid coloboma | Enrichment | PAX6 | 2.21 |
| 98 | Clear cell papillary renal cell carcinoma | Enrichment | HNF1A | 2.21 |
| 99 | Lens coloboma | Enrichment | PAX6 | 2.21 |
| 100 | Hypertrichosis | Enrichment | CREBBP | 2.15 |
| 101 | Rhabdomyosarcoma 2 | Enrichment | FOXO1 | 2.11 |
| 102 | Hemimegalencephaly | Enrichment | AKT3 | 2.11 |
| 103 | Aniridia | Enrichment | PAX6 | 2.11 |
| 104 | Coloboma of choroid and retina | Enrichment | PAX6 | 2.11 |
| 105 | Lung cancer susceptibility 3 | Enrichment | FGF10 | 2.08 |
| 106 | Coloboma of optic nerve | Enrichment | PAX6 | 2.03 |
| 107 | Hyperinsulinemic hypoglycemia, familial, 1 | Enrichment | GCK | 2.03 |
| 108 | Wilms tumor, aniridia, genitourinary anomalies, and impaired intellectual development syndrome | Enrichment | PAX6 | 2.03 |
| 109 | Anterior segment dysgenesis 5 | Enrichment | PAX6 | 2.03 |
| 110 | Clear cell renal cell carcinoma | Enrichment | HNF1A | 2.03 |
| 111 | Breast adenocarcinoma | Enrichment | AKT1 | 2.03 |
| 112 | Nonsyndromic genetic hyperinsulinism | Enrichment | GCK | 2.03 |
| 113 | Hypoplastic left heart syndrome | Enrichment | NOTCH1 | 2.03 |
| 114 | Charge syndrome | Enrichment | EP300 | 1.98 |
| 115 | Megacolon | Enrichment | AKT3 | 1.97 |
| 116 | Hemolytic anemia | Enrichment | PKLR | 1.97 |
| 117 | Combined pituitary hormone deficiency | Enrichment | FOXA2 | 1.91 |
| 118 | Cowden syndrome | Enrichment | AKT1 | 1.86 |
| 119 | Aortic valve disease 1 | Enrichment | NOTCH1 | 1.82 |
| 120 | Cat eye syndrome | Enrichment | PAX6 | 1.81 |
| 121 | Peters-plus syndrome | Enrichment | PAX6 | 1.81 |
| 122 | Polymicrogyria | Enrichment | AKT3 | 1.81 |
| 123 | Aortic aneurysm, familial thoracic 1 | Enrichment | NOTCH1 | 1.79 |
| 124 | Heart disease | Enrichment | CREBBP | 1.79 |
| 125 | Prostate cancer | Enrichment | HNF1B | 1.77 |
| 126 | Polydactyly, postaxial, type a1 | Enrichment | EP300 | 1.76 |
| 127 | Corpus callosum, agenesis of | Enrichment | CREBBP | 1.76 |
| 128 | Isolated corpus callosum agenesis | Enrichment | CREBBP | 1.76 |
| 129 | Intellectual disability-hypoplastic corpus callosum-preauricular tag syndrome | Enrichment | CREBBP | 1.76 |
| 130 | Digeorge syndrome | Enrichment | HNF1A | 1.73 |
| 131 | Meningioma | Enrichment | AKT1 | 1.73 |
| 132 | Congenital long qt syndrome | Enrichment | SLC2A2 | 1.73 |
| 133 | Cakut | Enrichment | HNF1B | 1.70 |
| 134 | Microphthalmia/coloboma 12 | Enrichment | PAX6 | 1.70 |
| 135 | Coloboma of macula | Enrichment | PAX6 | 1.64 |
| 136 | Anterior segment dysgenesis | Enrichment | PAX6 | 1.64 |
| 137 | Polycystic liver disease | Enrichment | HNF4A | 1.58 |
| 138 | Autosomal dominant polycystic liver disease | Enrichment | HNF4A | 1.58 |
| 139 | Scoliosis | Enrichment | CREBBP | 1.55 |
| 140 | Colorectal cancer | Enrichment | AKT1, EP300 | 1.55 |
| 141 | Tetralogy of fallot | Enrichment | NOTCH1 | 1.52 |
| 142 | Macs syndrome | Enrichment | PAX6 | 1.52 |
| 143 | Microphthalmia | Enrichment | PAX6 | 1.47 |
| 144 | Primary ovarian insufficiency | Enrichment | NR5A2 | 1.46 |
| 145 | Connective tissue disease | Enrichment | NOTCH1 | 1.43 |
| 146 | Long qt syndrome 1 | Enrichment | SLC2A2 | 1.34 |
| 147 | Familial thoracic aortic aneurysm and aortic dissection | Enrichment | NOTCH1 | 1.30 |
| 148 | Myeloma, multiple | Enrichment | CREBBP | 1.19 |
| 149 | Hereditary breast carcinoma | Enrichment | AKT1 | 1.18 |
| 150 | Hypertelorism | Enrichment | PAX6 | 1.11 |
| 151 | Autism | Enrichment | CREBBP | 1.09 |
| 152 | Hereditary retinal dystrophy | Enrichment | NEUROD1 | 1.08 |
| 153 | Fundus dystrophy | Enrichment | NEUROD1 | 1.08 |
| 154 | Congenital nervous system abnormality | Enrichment | CREBBP | 0.93 |
| 155 | Nervous system disease | Enrichment | CREBBP | 0.93 |
| 156 | Microcephaly | Enrichment | EP300 | 0.87 |